Liver Cancer Webinar Series
Machine-Learning Algorithms for the Early Detection of Hepatocellular Carcinoma
Panelist: Dr. Anand Mehta, SmartState Endowed Chair in Proteomic Biomarkers at the Medical University of South Carolina
Addressing Hepatocellular Carcinoma in Resource-Limited Settings
Panelists: Professor Mark Sonderup, Professor in the Department of Medicine and Acting Head of the Division of Hepatology, University of Cape Town, South Africa
Dr. Gibril Ndow, Head of Hepatitis Research Group, MRC Unit, The Gambia, London School of Hygiene and Tropical Medicine
Learn the Link: Introducing New Culturally Tailored Materials to Highlight the Connection between Hepatitis B and Liver Cancer
Panelists: Farma Pene, Project Coordinator, Viral Hepatitis Program, NYC Department of Health & Mental Hygiene
Serina Cao & Ariana Hung, Co-Chairs, Team HBV
Espi, #justB storyteller
Binh Tran, Program Director, Asian Pacific Health Foundation
Azeb Yusuf, Columbus Department of Public Health
Rensely Alik, Director, Micronesian Education Liver Wellness Program
Effectively Addressing High Rates of Liver Cancer in African Communities
Panelists: Dr. Kenneth D Rothstein, Professor of Clinical Medicine, University of Pennsylvania
View Webinar
Understanding Disparities in Hep B & Liver Cancer Screening Among High Risk Communities in the US
Panelists: Dr. Patricia Jones, Hepatologist and Researcher, University of Miami
Dr. Moon Chen, Professor and Associate Director of Community Outreach and Engagement, UC Davis Comprehensive Cancer Center
Kenson Alik, Director, Micronesian Education for Liver Wellness Program, Honolulu, HI
Janet Afoakwah, MPH, Executive Director, United States Coalition on African Immigrant Health
Treatment Options for Liver Cancer
Presented by: Robert G. Gish, MD, Professor and Consultant, Stanford University, and Medical Director, Hepatitis B Foundation
On behalf of the Hepatitis B Foundation’s Liver Cancer Connect program, world-renowned liver disease specialist Dr. Robert Gish talks about treatment options for liver cancer. How does the stage of the cancer affect treatment? Why are screening and surveillance so important? What are the available treatments and what are the therapies in development? Find out by listening to the webinar!
Download the Question & Answer Session
Clinical Trials in Liver Cancer
Presented by: Jill McNair, CISCRP, and Kate Levy, BS, Johns Hopkins Gastroenterology & Hepatology
Download the Question & Answer Session
Support Services for Families Facing Liver Cancer
Presented by: Karla Pillote, MSN, CANP, Johns Hopkins Gastroenterology & Hepatology and
Andrea Wilson, MPW, Blue Faery: The Adrienne Wilson Liver Cancer Association
Download the Question & Answer Session